I. Poveda‐Montoyo

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Sergio Santos-Alarcón, Javier Mataix Díaz, Luca Schneller‐Pavelescu, Isabel Belinchon et autres

OBJECTIVE: To evaluate the effectiveness and safety of switching to tildrakizumab, a selective interleukin (IL) 23p19 inhibitor, in patients with moderate-to-severe plaque psoriasis who had an inadequate response to ustekinumab (IL-12/23 inhibitor) in a real-world setting. METHODS: A multicenter retrospective observational study …

es, tr (code pays fourni par la source)

Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences

I. Poveda‐Montoyo, Pedro J. Álvarez‐Chinchilla, L. Schneller-Pavelescu, P. Hispán-Ocete et autres

Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe treatment modalities, clinical outcomes, and management of recurrence in patients receiving imiquimod for lentigo maligna. Patients from our unit with lentigo maligna or …

es (code pays fourni par la source)

[Artículo traducido] Serie de 14 casos de tratamiento con imiquimod tópico al 5% en lentigo maligno: modalidades terapéuticas y claves para detectar recidivas

I. Poveda‐Montoyo, Pedro J. Álvarez‐Chinchilla, L. Schneller-Pavelescu, P. Hispán-Ocete et autres

Imiquimod tópico ha sido utilizado como monoterapia o tratamiento adyuvante fuera de indicación para el lentigo maligno (LM). Nuestro objetivo es describir las modalidades de tratamiento, los resultados clínicos y el manejo de la recidiva en los pacientes que reciben imiquimod para …

es (code pays fourni par la source)

Quality Indicators in Care of Patients With Atopic Dermatitis: Consensus Document of the Spanish Academy of Dermatology and Venereology

I. Poveda‐Montoyo, Ignacio García-Doval, M.Á. Descalzo, Isabel Betlloch et autres

No information is currently available on whether the available clinical practice guidelines on the management of atopic dermatitis are known or being applied in Spain. The aim of this study was to improve the care of patients with atopic dermatitis by developing …

es, ch (code pays fourni par la source)

Are chilblain‐like acral skin lesions really indicative of COVID‐19? A prospective study and literature review

Alexandre Docampo‐Simón, María José Sánchez‐Pujol, Gloria Juan‐Carpena, Juan Carlos Palazón‐Cabanes et autres

][4] However, our histological findings are reminiscent of the pauci-inflammatory thrombogenic vasculopathy that occurs seriously ill hospitalized COVID-19 patients with COVID-19. This thrombogenic vasculopathy is due to activation of the complement pathways and an associated procoagulant state. However, no cases of thrombotic …

es (code pays fourni par la source)

Indicadores de calidad en la atención dermatológica a pacientes con dermatitis atópica. Documento de consenso de la Academia Española de Dermatología y Venereología

I. Poveda‐Montoyo, Ignacio García-Doval, M.Á. Descalzo, Isabel Betlloch et autres

El grado de conocimiento y aplicación de las guías de práctica clínica sobre el manejo de la dermatitis atópica son desconocidos en nuestro entorno. El objetivo de este estudio es elaborar indicadores de calidad basados en las guías de práctica clínica existentes, …

es (code pays fourni par la source)

Topics and PRISMA Checklist Compliance for Meta-analyses in Dermatology: Journal Case Study.

I. Poveda‐Montoyo, I. Belinchón, David Romero‐Pérez, José Manuel Ramos

Meta-analyses are usually the final step of systematic reviews and provide robust scientific evidence (1,2). The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement is a useful tool to improve the reporting of meta-analyses (3). There are few data available …

es, it (code pays fourni par la source)

Image Gallery: Segmental neurofibromatosis type 1 on the face. A 30‐year delay in diagnosis

Eduardo Vergara‐de Caso, Luca Schneller‐Pavelescu, María C. Martínez-Hergueta, Pedro J. Álvarez‐Chinchilla et autres

Funding sources: none. Conflicts of interest: none to declare. Dear Editor, We present a 61‐year‐old man referred for two nodular lesions on the right upper lip and multiple papules around the ipsilateral nasolabial fold, all of them long‐standing (30 years) and asymptomatic …

es (code pays fourni par la source)

Cutaneous lesions in hereditary hemorrhagic telangiectases (Osler‐Weber‐Rendu disease): retrospective case series in 23 patients

Pedro J. Álvarez‐Chinchilla, I. Poveda‐Montoyo, Eduardo Vergara‐de Caso, Luca Schneller‐Pavelescu et autres

es (code pays fourni par la source)

Cetearyl isononanoate, an underestimated contact allergen?

Pedro J. Álvarez‐Chinchilla, I. Poveda‐Montoyo, Iris González

es (code pays fourni par la source)

Retronychia a little‐known cause of paronychia: A report of two cases in adolescent patients

I. Poveda‐Montoyo, Eduardo Vergara‐de Caso, David Romero‐Pérez, Isabel Betlloch

Retronychia is a clinical condition resulting from embedding of the nail plate into the proximal nail fold. We report two adolescent girls, 14 and 16 years of age, with a history of chronic proximal paronychia of the great toe, one of them …

es (code pays fourni par la source)

Spiramycin‐related cutaneous eruption confirmed by patch testing

I. Poveda‐Montoyo, Pedro J. Álvarez‐Chinchilla, M.C. García del Pozo, Belén Encabo

es (code pays fourni par la source)